Abstract:Globally, metabolic dysfunction-associated steatotic liver disease (MASLD), previously termed nonalcoholic fatty liver disease (NAFLD), is one of the most common liver disorders and is strongly associated with copper deficiency. To explore the potential effects and mechanisms of Lactiplantibacillus plantarum LPJZ-658, copper deficiency combined with a high-sugar diet-induced MASLD mouse model was utilized in this study. We fed 40-week-old (middle-aged) male C57BL/6 mice a copper-deficient and high-sugar diet for 16 weeks (CuDS), with supplementary LPJZ-658 for the last 6 weeks (CuDS + LPJZ-658). In this study, we measured body weight, liver weight, and serum biochemical markers. Lipid accumulation, histology, lipidomics, and sphingolipid metabolism-related enzyme expression were investigated to analyze liver function. Untargeted metabolomics was used to analyze the serum and the composition and abundance of intestinal flora. In addition, the correlation between differential liver lipid profiles, serum metabolites, and gut flora at the genus level was measured. The results show that LPJZ-658 significantly improves abnormal liver function and hepatic steatosis. The lipidomics analyses and metabolic pathway analysis identified sphingolipid, retinol, and glycerophospholipid metabolism as the most relevant metabolic pathways that characterized liver lipid dysregulation in the CuDS group. Consistently, RT-qPCR analyses revealed that the enzymes catalyzing sphingolipid metabolism that were significantly upregulated in the CuDS group were downregulated by the LPJZ-658 treatment. In addition, the serum metabolomics results indicated that the linoleic acid, taurine and hypotaurine, and ascorbate and aldarate metabolism pathways were associated with CuDS-induced MASLD. Notably, we found that treatment with LPJZ-658 partially reversed the changes in the differential serum metabolites. Finally, LPJZ-658 effectively regulated intestinal flora abnormalities and was significantly correlated with differential hepatic lipid species and serum metabolites. In conclusion, we elucidated the function and potential mechanisms of LPJZ-658 in alleviating copper deficiency combined with sugar-induced middle-aged MASLD and hope this will provide possible treatment strategies for improving MASLD.

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to explore the regulatory effect and mechanism of Lactobacillus strain LPJZ - 658 on copper - deficiency - combined - sugar - induced metabolic - dysfunction - associated - steatotic - liver disease (MASLD) in middle - aged mice. Specifically, the study constructs a MASLD mouse model induced by copper deficiency and a high - sugar diet, evaluates the improvement effect of LPJZ - 658 on liver dysfunction and hepatic steatosis, and reveals its potential mechanism of action through multi - omics analysis (including lipidomics, metabolomics and gut microbiome analysis). ### Research Background - **MASLD**: Metabolic - dysfunction - associated - steatotic - liver disease, formerly known as non - alcoholic - fatty - liver - disease (NAFLD), is one of the most common liver diseases in the world and is closely related to copper deficiency. - **Copper Deficiency**: Copper is an important trace element and plays a crucial role in maintaining normal cell functions. Copper deficiency will exacerbate liver fat accumulation and lead to the development of MASLD. - **High - Sugar Diet**: Excessive sugar intake further promotes the development of MASLD, especially fructose intake is related to the occurrence of MASLD. - **Probiotics**: Probiotics such as LPJZ - 658 have been proven to improve gut health, regulate lipid metabolism and alleviate MASLD symptoms. ### Research Objectives - **Evaluating the Effect of LPJZ - 658**: Through experimental design, evaluate the impact of LPJZ - 658 on the MASLD mouse model induced by copper deficiency combined with a high - sugar diet. - **Mechanism Exploration**: Use multi - omics analysis methods (lipidomics, metabolomics and gut microbiome analysis) to reveal the potential mechanism of LPJZ - 658 in improving MASLD. ### Main Findings - **Body Weight and Blood Metabolites**: There were no significant differences in the body weight, liver weight and serum metabolite levels of the mice in the LPJZ - 658 treatment group, but the serum AST level was significantly decreased, indicating that LPJZ - 658 may be effective in preventing liver injury. - **Hepatic Steatosis**: H&E staining and lipidomics analysis showed that LPJZ - 658 significantly reduced the formation of liver lipid droplets and the intrahepatic triglyceride level, indicating its improvement effect on hepatic steatosis. - **Metabolomics**: Serum metabolomics analysis found that LPJZ - 658 partially reversed the metabolic changes caused by copper deficiency and a high - sugar diet, especially metabolites related to the linoleic acid, taurine and hypotaurine, ascorbic acid and hexuronic acid metabolic pathways. - **Gut Microbiome**: LPJZ - 658 significantly regulated the abnormalities of the gut microbiota, especially increased the relative abundance of beneficial bacteria such as Faecalibaculum and decreased the relative abundance of harmful bacteria such as Ruminococcus torques group. - **Correlation Analysis**: There was a significant correlation between the changes in the liver lipid metabolome and serum metabolome caused by LPJZ - 658 and the changes in the gut microbiota. ### Conclusion This study reveals the function and potential mechanism of LPJZ - 658 in improving MASLD induced by copper deficiency combined with a high - sugar diet, providing a new strategy for the treatment of MASLD.

Exploring the Regulatory Effect of LPJZ-658 on Copper Deficiency Combined with Sugar-Induced MASLD in Middle-Aged Mice Based on Multi-Omics Analysis

Lactobacillus Casei YRL577 Combined with Plant Extracts Reduce Markers of Non-Alcoholic Fatty Liver Disease in Mice

Lactiplantibacillus plantarum LPJZ-658 Improves Non-Alcoholic Steatohepatitis by Modulating Bile Acid Metabolism and Gut Microbiota in Mice

Ileum Proteomics Identifies Distinct Pathways Associated with Different Dietary Doses of Copper-Fructose Interactions: Implications for the Gut-Liver Axis and MASLD

Lingguizhugan oral solution alleviates MASLD by regulating bile acids metabolism and the gut microbiota through activating FXR/TGR5 signaling pathways

Metabolic Dysfunction-Associated Steatotic Liver Disease Is Accompanied by Increased Activities of Superoxide Dismutase, Catalase, and Carbonyl Reductase 1 and Levels of miR-200b-3p in Mouse Models

Mixture of Peanut Skin Extract, Geniposide, and Isoquercitrin Improves the Hepatic Lipid Accumulation of Mice Via Modification of Gut Microbiota Homeostasis and the TLR4 and AMPK Signaling Pathways

Modulation of the Microbiome-Fat-Liver Axis by Lactic Acid Bacteria: A Potential Alleviated Role in High-Fat-Diet-Induced Obese Mice.

Combination of Probiotics and Salvia miltiorrhiza Polysaccharide Alleviates Hepatic Steatosis via Gut Microbiota Modulation and Insulin Resistance Improvement in High Fat-Induced NAFLD Mice

Phocaeicola vulgatus alleviates diet-induced metabolic dysfunction-associated steatotic liver disease progression by downregulating histone acetylation level via 3-HPAA

Updated mechanisms of MASLD pathogenesis

Lactobacillus plantarum ZJUIDS14 alleviates non-alcoholic fatty liver disease in mice in association with modulation in the gut microbiota

Changes in liver metabolic pathways demonstrate efficacy of the combined dietary and microbial therapeutic intervention in MASLD mouse model

High dietary Fructose Drives Metabolic Dysfunction-Associated Steatotic Liver Disease via Activating ubiquitin-specific peptidase 2/11β-hydroxysteroid dehydrogenase type 1 Pathway in Mice

Effects of Ganjianglingzhu Decoction on Lean Non-Alcoholic Fatty Liver Disease in Mice Based on Untargeted Metabolomics

Helicobacter pylori infection exacerbates metabolic dysfunction-associated steatotic liver disease through lipid metabolic pathways: a transcriptomic study

Lycorine ameliorates liver steatosis, oxidative stress, ferroptosis and intestinal homeostasis imbalance in MASLD mice

Effects of Shenling Baizhu powder on intestinal microflora metabolites and liver mitochondrial energy metabolism in nonalcoholic fatty liver mice

Anaerobutyricum soehngenii Reduces Hepatic Lipogenic Pathways and Increases Intestinal Gluconeogenic Gene Expression in Metabolic-Dysfunction-Associated Steatotic Liver Disease (MASLD) Mice

Multiomics analyses decipher intricate changes in the cellular and metabolic landscape of steatotic livers upon dietary restriction and sleeve gastrectomy

Protective Effects of Lactobacillus plantarum CCFM8246 against Copper Toxicity in Mice